Ryman Healthcare Ltd. reported a loss in the first half of the year, with a loss of NZ$49.65 million compared to a profit of NZ$58.99 million the previous year. Loss per share was 4.4 cents, down from earnings per share of 11.8 cents last year. However, revenue increased to NZ$413.78 million from NZ$366.26 million. Despite the loss, Ryman Healthcare’s stock closed 2.0979% higher at NZ$2.9200 on the New Zealand Stock Exchange.

Read more at Nasdaq: Ryman Healthcare Slid To Loss In H1